Stocks
Editas Medicine (EDIT) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -736.3% | -1 114% | -208.8% | -721.4% | -366.8% | -261.5% | ||
| Changes by years, y/y, % | -592pp | -378pp | +905pp | -513pp | +355pp | +20.5% | |||
Editas Medicine. EBITDA margin, %
Editas Medicine. EBITDA margin, changes, pp
Editas Medicine (EDIT) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | -1 380% | -291.6% | -21.3% | -827.5% | -164.2% | -261.5% | |
| Changes by years, y/y, % | +12 359pp | +98 958pp | +86pp | +717pp | +1 216pp | |||
| Changes by quarters, q/q, % | +165pp | +1 089pp | +270pp | -806pp | +663pp | |||
